Deutsche Bank Analysts Give Carl Zeiss Meditec (AFX) a €40.00 Price Target
Carl Zeiss Meditec (ETR:AFX) has been assigned a €40.00 ($47.62) price target by analysts at Deutsche Bank in a research note issued to investors on Friday. The firm currently has a “neutral” rating on the stock. Deutsche Bank’s target price indicates a potential downside of 19.08% from the company’s current price.
A number of other brokerages have also commented on AFX. Berenberg Bank set a €48.00 ($57.14) price objective on Carl Zeiss Meditec and gave the company a “buy” rating in a research report on Monday, August 7th. Kepler Capital Markets set a €48.50 ($57.74) price target on Carl Zeiss Meditec and gave the company a “buy” rating in a research note on Monday, August 7th. set a €52.00 ($61.90) price target on Carl Zeiss Meditec and gave the company a “buy” rating in a research note on Friday, November 10th. Commerzbank set a €42.00 ($50.00) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Tuesday, August 8th. Finally, Independent Research set a €44.00 ($52.38) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Tuesday, August 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of €46.64 ($55.53).
Carl Zeiss Meditec (AFX) opened at €49.43 ($58.85) on Friday. Carl Zeiss Meditec has a 12-month low of €31.22 ($37.17) and a 12-month high of €49.83 ($59.32).
WARNING: “Deutsche Bank Analysts Give Carl Zeiss Meditec (AFX) a €40.00 Price Target” was posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/12/01/deutsche-bank-analysts-give-carl-zeiss-meditec-afx-a-40-00-price-target.html.
Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.